<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="105843">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01839162</url>
  </required_header>
  <id_info>
    <org_study_id>ASLRMB-Pertini1</org_study_id>
    <nct_id>NCT01839162</nct_id>
  </id_info>
  <brief_title>RAdiation Dose In percutAneuos Coronary Procedures Through TransradIal apprOach Using Dedicated radiatioN Shields</brief_title>
  <acronym>RADIATION</acronym>
  <official_title>RAdiation Dose In percutAneuos Coronary Procedures Through TransradIal apprOach Using Dedicated radiatioN Shields (The RADIATION Study)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Ospedale Sandro Pertini, Roma</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Ospedale Sandro Pertini, Roma</source>
  <oversight_info>
    <authority>Italy: AIFA (Agenzia Italiana del Farmaco)</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      During percutaneous coronary interventions standard operator radio-protection is generally
      ensured using a lead apron, a thyroid lead collar, low leaded flaps, an upper mobile leaded
      glass suspended from the ceiling and leaded glasses. Previous studies showed that adding a
      bismuth-barium radiation shield drape on the patient right arm or using a pelvic lead shield
      on the patient, the radiation dose adsorbed by operators was significantly reduced even if
      was higher compared to transfemoral approach. No studies evaluated the effect of both
      adjunctive shields placed in the same patient.

      Aim of our randomized study is to evaluate if the combination of a shield drape on the
      patient right arm and a pelvic lead shield during transradial percutaneous coronary
      procedures may reduce the radiation dose adsorbed by operators compared to the use of only
      one shield or none.

      All patients who underwent to percutaneous coronary diagnostic or interventional procedures
      will be enrolled in this randomized study. Eligible patients will be randomized (using a
      computer generated randomization sequence) in 4 groups:

        1. use of a pelvic shield drape

        2. use of a shield drape on the patient right arm

        3. use of a pelvic shield drape and a shield drape on the patient right arm

        4. Any adjunctive shield drape (only standard radio-protection) For each group a further
           internal randomization will be performed in order to compare the right or left radial
           transradial approach.

      Each operator will be equipped with dedicated dosimeters placed at left wrist and at thorax
      level outside the lead apron.

      Primary end-point of the study is the radiation dose adsorbed at wrist and thorax by
      operators and detected by the electronic dosimeters.

      Secondary end-point are:

        1. Radiation dose adsorbed by operators according to the radial access (right versus left)

        2. Radiation dose adsorbed by the patients
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">December 2014</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention</study_design>
  <primary_outcome>
    <measure>Radiation dose adsorbed by operators</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Primary end-point of the study is the radiation dose adsorbed at wrist and thorax by operators and detected by the electronic dosimeters</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Radiation dose adsorbed by operators according to the radial access (right versus left)</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiation dose adsorbed by operators according to the radial access (right versus left)</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Radiation dose adsorbed by the patients</measure>
    <time_frame>During procedure</time_frame>
    <safety_issue>No</safety_issue>
    <description>Radiation dose adsorbed by the patients</description>
  </secondary_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">400</enrollment>
  <condition>Myocardial Ischemia</condition>
  <arm_group>
    <arm_group_label>Pelvic drape</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pelvic shield drape over the patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Arm drape</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Right radial arm drape over the patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pelvic and arm drape</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Pelvic and arm drpaes placed over the patient</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No  drapes</arm_group_label>
    <arm_group_type>Sham Comparator</arm_group_type>
    <description>Standard radioprotection devices</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Coronary angiography</intervention_name>
    <description>Diagnostic coronary angiography</description>
    <arm_group_label>Pelvic drape</arm_group_label>
    <arm_group_label>Arm drape</arm_group_label>
    <arm_group_label>Pelvic and arm drape</arm_group_label>
    <arm_group_label>No  drapes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCI</intervention_name>
    <description>Percutaneous coronary intervention</description>
    <arm_group_label>Pelvic drape</arm_group_label>
    <arm_group_label>Arm drape</arm_group_label>
    <arm_group_label>Pelvic and arm drape</arm_group_label>
    <arm_group_label>No  drapes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Right approach</intervention_name>
    <description>Right transradial access</description>
    <arm_group_label>Pelvic drape</arm_group_label>
    <arm_group_label>Arm drape</arm_group_label>
    <arm_group_label>Pelvic and arm drape</arm_group_label>
    <arm_group_label>No  drapes</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Left approach</intervention_name>
    <description>Left transradial access</description>
    <arm_group_label>Pelvic drape</arm_group_label>
    <arm_group_label>Arm drape</arm_group_label>
    <arm_group_label>Pelvic and arm drape</arm_group_label>
    <arm_group_label>No  drapes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        All patients who underwent to percutaneous coronary diagnostic or interventional
        procedures will be enrolled in this randomized study

        Exclusion Criteria:

          1. Previous coronary artery by-pass

          2. Acute ST elevation myocardial infarction

          3. Hemodynamic instability or cardiogenic shock

          4. Ischemic Allen test.
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Alessandro Sciahbasi, MD</last_name>
    <phone>+390641433871</phone>
    <email>alessandro.sciahbasi@fastwebnet.it</email>
  </overall_contact>
  <location>
    <facility>
      <name>Ospedale Sandro Pertini - ASL RMB- UOSD Emodinamica</name>
      <address>
        <city>Rome</city>
        <country>Italy</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Alessandro Sciahbasi, MD</last_name>
      <phone>+390641433871</phone>
      <email>alessandro.sciahbasi@fastwebnet.it</email>
    </contact>
    <contact_backup>
      <last_name>Stefano Rigattieri, MD</last_name>
      <phone>+390641433871</phone>
      <email>stefanorigattieri@yahoo.it</email>
    </contact_backup>
    <investigator>
      <last_name>Alessandro Sciahbasi, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Stefano Rigattieri, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Italy</country>
  </location_countries>
  <verification_date>October 2013</verification_date>
  <lastchanged_date>October 26, 2013</lastchanged_date>
  <firstreceived_date>April 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Ospedale Sandro Pertini, Roma</investigator_affiliation>
    <investigator_full_name>Alessandro Sciahbasi, MD</investigator_full_name>
    <investigator_title>Interventional Cardiologist</investigator_title>
  </responsible_party>
  <keyword>Transradial approach</keyword>
  <keyword>shield drape</keyword>
  <keyword>radiation</keyword>
  <keyword>PTCA</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Myocardial Ischemia</mesh_term>
    <mesh_term>Coronary Artery Disease</mesh_term>
    <mesh_term>Ischemia</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
